Wang et al. reported that curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves the down-regulation of nuclear endonuclease G and NF-κB, as well as the induction of apoptosis and G2/M arrest48, which is consistent with our results. Here, NFKB1 is linked to cancer.